title: Vaginismus: review of current concepts and treatment using botox injections, bupivacaine injections, and progressive dilation with the patient under anesthesia.
abstract: Vaginismus is a poorly understood condition affecting approximately 1-7% of females worldwide. This article aims to bring attention to this disorder and to review the use of Botox injections to treat these patients. Vaginismus, also known as vaginal penetration disorder, is an aversion to any form of vaginal penetration as a result of painful attempts and a fear of anticipated pain. It is involuntary and uncontrolled and functions much the same as any reflex to avoid injury. It is the most common reason for unconsummated marriages. The etiology is thought to be unknown. Numerous papers note a history of religious or strict sexual upbringing or aversion to penetration because of perceived pain and bleeding with first-time intercourse. Sexual molestation may be more prevalent in this group of patients. The Lamont classification is very helpful in stratifying these patients for treatment. Lamont grade 5 vaginismus is introduced. Vaginal Botox injections for the treatment of vaginismus has received increasing attention since the technique was first described in a 1997 case report. Plastic surgeons worldwide with their experience using Botox are well positioned to learn more about this relatively unknown entity and render treatment.
authors.affiliation: Plastic Surgery Professional Association, 57 Bay Street, Manchester, NH 03104, USA. info@plasticsurgerypa.com
authors.forename: Peter T
authors.initials: PT
authors.lastname: Pacik
mesh_terms: D000779:Anesthetics, Local / Q000008:administration & dosage*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002045:Bupivacaine / Q000008:administration & dosage*; D002404:Catheterization; D005260:Female; D006801:Humans; D007267:Injections; D052065:Vaginismus / Q000628:therapy*
chemical_list: D000779:Anesthetics, Local; D019274:Botulinum Toxins, Type A; D002045:Bupivacaine